Thursday, May 26, 2022 8:10:26 PM
New York Yankees and Duke Basketball
Recent PMVP News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/10/2024 08:17:57 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/07/2024 12:32:32 PM
- PMV Pharmaceuticals to Participate at Upcoming Investor Conferences in June • GlobeNewswire Inc. • 05/30/2024 11:00:00 AM
- Foundation Medicine and PMV Pharma Announce Collaboration to Develop Companion Diagnostic for Rezatapopt, a First-In-Class, Investigational, Selective p53 Y220C Reactivator • GlobeNewswire Inc. • 05/29/2024 11:00:00 AM
- Foundation Medicine and PMV Pharma Announce Collaboration to Develop Companion Diagnostic for Rezatapopt, a First-In-Class, Investigational, Selective p53 Y220C Reactivator • Business Wire • 05/29/2024 11:00:00 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/09/2024 12:00:33 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/09/2024 12:00:14 PM
- PMV Pharmaceuticals Reports First Quarter 2024 Financial Results and Corporate Highlights • GlobeNewswire Inc. • 05/09/2024 12:00:00 PM
- PMV Pharmaceuticals Announces First Patient Dosed in Global Tumor-Agnostic Phase 2 PYNNACLE Trial for Rezatapopt in TP53 Y220C-Positive Solid Tumors • GlobeNewswire Inc. • 03/27/2024 12:00:00 PM
- PMV Pharmaceuticals PYNNACLE Phase I Data of Rezatapopt in Advanced Ovarian Cancer Featured in Late-Breaking Oral Presentation at 2024 SGO Annual Meeting on Women’s Cancer • GlobeNewswire Inc. • 03/18/2024 08:01:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/29/2024 09:05:19 PM
- PMV Pharmaceuticals Reports Full Year 2023 Financial Results and Corporate Highlights • GlobeNewswire Inc. • 02/29/2024 09:01:00 PM
- PMV Pharmaceuticals to Participate in the TD Cowen 44th Annual Health Care Conference • GlobeNewswire Inc. • 02/26/2024 01:00:00 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 01/24/2024 02:01:32 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/22/2024 09:06:16 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/22/2024 09:04:03 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/18/2024 09:02:53 PM
- PMV Pharmaceuticals Announces Prioritization of PC14586 Clinical Development and Extended Cash Runway • GlobeNewswire Inc. • 01/18/2024 09:01:00 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 01/11/2024 09:18:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/05/2024 09:01:59 PM
- PMV Pharmaceuticals Strengthens Leadership with Key Appointments as Company Advances into Late-Stage Development • GlobeNewswire Inc. • 01/05/2024 09:01:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 01:00:48 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/09/2023 01:00:42 PM
- PMV Pharmaceuticals Reports Third Quarter 2023 Financial Results and Corporate Highlights • GlobeNewswire Inc. • 11/09/2023 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/12/2023 09:02:32 PM
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM